$PRSO
Peraso Inc.

2024 Q4 Form 10-Q Financial Statement

#000121390024097140 Filed on November 13, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.841M
YoY Change -14.28%
Cost Of Revenue $2.034M
YoY Change -16.81%
Gross Profit $1.807M
YoY Change -11.25%
Gross Profit Margin 47.05%
Selling, General & Admin $2.349M
YoY Change 11.22%
% of Gross Profit 129.99%
Research & Development $2.158M
YoY Change -38.06%
% of Gross Profit 119.42%
Depreciation & Amortization $981.0K
YoY Change -6.57%
% of Gross Profit 54.29%
Operating Expenses $4.507M
YoY Change -19.46%
Operating Profit -$2.700M
YoY Change -24.16%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net -$16.00K
YoY Change -100.54%
Pretax Income -$2.712M
YoY Change 337.42%
Income Tax
% Of Pretax Income
Net Earnings -$2.712M
YoY Change 335.31%
Net Earnings / Revenue -70.61%
Basic Earnings Per Share -$0.98
Diluted Earnings Per Share -$0.98
COMMON SHARES
Basic Shares Outstanding 3.430M shares 2.746M shares
Diluted Shares Outstanding 2.780M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $1.317M
YoY Change 88.14%
Cash & Equivalents $1.317M
Short-Term Investments
Other Short-Term Assets $635.0K
YoY Change -20.63%
Inventory $2.503M
Prepaid Expenses
Receivables $791.0K
Other Receivables $0.00
Total Short-Term Assets $5.246M
YoY Change -48.72%
LONG-TERM ASSETS
Property, Plant & Equipment $643.0K
YoY Change -60.41%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $121.0K
YoY Change 0.0%
Total Long-Term Assets $1.949M
YoY Change -70.47%
TOTAL ASSETS
Total Short-Term Assets $5.246M
Total Long-Term Assets $1.949M
Total Assets $7.195M
YoY Change -57.25%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.705M
YoY Change -33.99%
Accrued Expenses $2.399M
YoY Change 139.9%
Deferred Revenue $555.0K
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.873M
YoY Change 31.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $197.0K
YoY Change -85.93%
Total Long-Term Liabilities $197.0K
YoY Change -85.93%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.873M
Total Long-Term Liabilities $197.0K
Total Liabilities $5.169M
YoY Change 1.83%
SHAREHOLDERS EQUITY
Retained Earnings -$175.6M
YoY Change 11.5%
Common Stock $3.000K
YoY Change -88.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $2.026M
YoY Change
Total Liabilities & Shareholders Equity $7.195M
YoY Change -57.25%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income -$2.712M
YoY Change 335.31%
Depreciation, Depletion And Amortization $981.0K
YoY Change -6.57%
Cash From Operating Activities -$683.0K
YoY Change -66.84%
INVESTING ACTIVITIES
Capital Expenditures $0.00
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change -100.0%
Cash From Investing Activities $0.00
YoY Change -100.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 132.0K
YoY Change
NET CHANGE
Cash From Operating Activities -683.0K
Cash From Investing Activities 0.000
Cash From Financing Activities 132.0K
Net Change In Cash -551.0K
YoY Change -62.26%
FREE CASH FLOW
Cash From Operating Activities -$683.0K
Capital Expenditures $0.00
Free Cash Flow -$683.0K
YoY Change -66.84%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2023Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2023Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2023Q4 prso Exchangeable Common Stock Value
ExchangeableCommonStockValue
usd
us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2023Q4 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2024Q3 us-gaap Preferred Stock Value
PreferredStockValue
usd
CY2024Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
shares
CY2024Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
shares
CY2024Q3 prso Exchangeable Common Stock Value
ExchangeableCommonStockValue
usd
CY2024Q3 us-gaap Common Stock No Par Value
CommonStockNoParValue
CY2023Q3 prso Severance And Software License Obligations
SeveranceAndSoftwareLicenseObligations
usd
prso Severance And Software License Obligations
SeveranceAndSoftwareLicenseObligations
usd
CY2024Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
CY2023Q3 us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
usd
CY2024Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-32929
dei Entity Registrant Name
EntityRegistrantName
PERASO INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
77-0291941
dei Entity Address Address Line1
EntityAddressAddressLine1
2309 Bering Drive
dei Entity Address City Or Town
EntityAddressCityOrTown
San Jose
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
95131
dei City Area Code
CityAreaCode
(408)
dei Local Phone Number
LocalPhoneNumber
418-7500
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
PRSO
dei Security Exchange Name
SecurityExchangeName
NASDAQ
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
3429959 shares
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1317000 usd
CY2023Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1583000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
791000 usd
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
731000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2503000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2606000 usd
CY2024Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
635000 usd
CY2023Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
620000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
5246000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
5540000 usd
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
643000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
1156000 usd
CY2024Q3 prso Rightofuse Lease Assets
RightofuseLeaseAssets
355000 usd
CY2023Q4 prso Rightofuse Lease Assets
RightofuseLeaseAssets
615000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
830000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3280000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
121000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
123000 usd
CY2024Q3 us-gaap Assets
Assets
7195000 usd
CY2023Q4 us-gaap Assets
Assets
10714000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
1705000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2448000 usd
CY2024Q3 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
2399000 usd
CY2023Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
611000 usd
CY2024Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
555000 usd
CY2023Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
1105000 usd
CY2024Q3 prso Lease Liabilities Current
LeaseLiabilitiesCurrent
214000 usd
CY2023Q4 prso Lease Liabilities Current
LeaseLiabilitiesCurrent
370000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4873000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4534000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
197000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
349000 usd
CY2024Q3 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
99000 usd
CY2023Q4 us-gaap Warrants And Rights Outstanding
WarrantsAndRightsOutstanding
1748000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5169000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6631000 usd
CY2024Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2023Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
120000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2856000 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2856000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
673000 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
673000 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
3000 usd
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
1000 usd
CY2024Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
87000 shares
CY2023Q4 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
95000 shares
CY2024Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
177583000 usd
CY2023Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
170474000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-175560000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-166392000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2026000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4083000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
7195000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
10714000 usd
CY2024Q3 us-gaap Revenues
Revenues
3841000 usd
CY2023Q3 us-gaap Revenues
Revenues
4481000 usd
us-gaap Revenues
Revenues
10895000 usd
us-gaap Revenues
Revenues
11916000 usd
CY2024Q3 us-gaap Cost Of Revenue
CostOfRevenue
2034000 usd
CY2023Q3 us-gaap Cost Of Revenue
CostOfRevenue
2445000 usd
us-gaap Cost Of Revenue
CostOfRevenue
5431000 usd
us-gaap Cost Of Revenue
CostOfRevenue
7346000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
1807000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
2036000 usd
us-gaap Gross Profit
GrossProfit
5464000 usd
us-gaap Gross Profit
GrossProfit
4570000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2158000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3484000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
7615000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
11038000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2349000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2112000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6592000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6331000 usd
prso Severance And Software License Obligations
SeveranceAndSoftwareLicenseObligations
2063000 usd
us-gaap Gain Loss On Sales Of Assets And Asset Impairment Charges
GainLossOnSalesOfAssetsAndAssetImpairmentCharges
406000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
4507000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
5596000 usd
us-gaap Operating Expenses
OperatingExpenses
16270000 usd
us-gaap Operating Expenses
OperatingExpenses
16963000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-2700000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-3560000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-10806000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12393000 usd
CY2024Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4000 usd
CY2023Q3 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-2615000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1649000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4239000 usd
CY2024Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-16000 usd
CY2023Q3 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
322000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-11000 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
297000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2712000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-623000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9168000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7857000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000 usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
25000 usd
CY2024Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2712000 usd
CY2023Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-619000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-9168000 usd
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-7832000 usd
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.98
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.98
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.87
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.87
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-3.62
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-3.62
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-12.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-12.43
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2780000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2780000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
715000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
715000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2530000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2530000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
632000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
632000 shares
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
4083000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3431000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1222000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2031000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
6706000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1000 usd
CY2024Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
127000 usd
CY2024Q2 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
4000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1155000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4425000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
3560000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
164000 usd
CY2024Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
54000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
960000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
-2712000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
2026000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
15257000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1307000 usd
CY2023Q1 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
14000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-3148000 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
13430000 usd
CY2023Q2 prso Stock Issued During Period Share Exchangeof Exchangeable Shares
StockIssuedDuringPeriodShareExchangeofExchangeableShares
-3000 usd
CY2023Q2 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
36000 usd
CY2023Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3546000 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
19000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
3162000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1319000 usd
CY2023Q2 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
7000 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-4086000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
11034000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
25000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1308000 usd
CY2023Q3 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
4000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
-623000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
11748000 usd
us-gaap Net Income Loss
NetIncomeLoss
-9168000 usd
us-gaap Net Income Loss
NetIncomeLoss
-7857000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2964000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2764000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3337000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
3933000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-1649000 usd
us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
-4239000 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
54000 usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
-154000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
8000 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
14000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
60000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-334000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-103000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
348000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
15000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
164000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
600000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-743000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
739000 usd
prso Increase Decrease In Rightofuse Assets
IncreaseDecreaseInRightofuseAssets
260000 usd
prso Increase Decrease In Rightofuse Assets
IncreaseDecreaseInRightofuseAssets
500000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-205000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-335000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
1238000 usd
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
-1386000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3892000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-5627000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
93000 usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
1100000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1007000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3559000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
3595000 usd
prso Proceeds From Atthemarket Sales Of Stock Net
ProceedsFromAtthemarketSalesOfStockNet
164000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
36000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
94000 usd
us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
78000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3626000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3481000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-266000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-1139000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1583000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1828000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1317000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
689000 usd
prso Initial Recognition Of Warrant Liability
InitialRecognitionOfWarrantLiability
3162000 usd
prso Unrealized Gainloss On Availableforsale Securities
UnrealizedGainlossOnAvailableforsaleSecurities
-25000 usd
CY2024Q3 us-gaap Net Investment In Lease Allowance For Credit Loss
NetInvestmentInLeaseAllowanceForCreditLoss
9200000 usd
CY2023Q4 us-gaap Net Investment In Lease Allowance For Credit Loss
NetInvestmentInLeaseAllowanceForCreditLoss
16800000 usd
CY2024Q3 us-gaap Retained Earnings Unappropriated
RetainedEarningsUnappropriated
175600000 usd
CY2024Q1 prso Net Proceeds From Common Stock And Warrants
NetProceedsFromCommonStockAndWarrants
3400000 usd
us-gaap Use Of Estimates
UseOfEstimates
<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif"><b><i>Use of Estimates</i></b></span></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses recognized during the reported period. Material estimates may include assumptions made in determining reserves for uncollectible receivables, inventory write-downs, impairment of long-term assets, valuation allowance on deferred tax assets, accruals for potential liabilities and assumptions made in valuing equity instruments and warrant liabilities. Actual results could differ from those estimates.</span></p>
prso Specific Allowance
SpecificAllowance
1 pure
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
30000 usd
CY2023Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
30000 usd
us-gaap Inventory Write Down
InventoryWriteDown
319000 usd
us-gaap Inventory Write Down
InventoryWriteDown
793000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8468000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-7638000 usd
CY2024Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
830000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
8468000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
-5082000 usd
CY2023 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
106000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3280000 usd
CY2024Q3 us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
2000 usd
us-gaap Other Depreciation And Amortization
OtherDepreciationAndAmortization
5000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
799000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
8417000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
342000 shares
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
108000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
209000 usd
CY2024Q3 us-gaap Inventory Work In Process
InventoryWorkInProcess
1407000 usd
CY2023Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
1517000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
988000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
880000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
2503000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
2606000 usd
CY2024Q3 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
422000 usd
CY2023Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
405000 usd
CY2024Q3 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
203000 usd
CY2023Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
158000 usd
CY2024Q3 us-gaap Program Rights Obligations
ProgramRightsObligations
1048000 usd
CY2024Q3 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
250000 usd
CY2024Q3 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
29000 usd
CY2023Q4 us-gaap Extended Product Warranty Accrual
ExtendedProductWarrantyAccrual
37000 usd
CY2024Q3 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
447000 usd
CY2023Q4 us-gaap Other Accounts Payable And Accrued Liabilities
OtherAccountsPayableAndAccruedLiabilities
11000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
2399000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
611000 usd
us-gaap Severance Costs1
SeveranceCosts1
446000 usd
CY2024Q2 us-gaap Contractual Interest Expense On Prepetition Liabilities Not Recognized In Statement Of Operations
ContractualInterestExpenseOnPrepetitionLiabilitiesNotRecognizedInStatementOfOperations
1617000 usd
CY2024Q3 us-gaap Contractual Obligation
ContractualObligation
0.000001 usd
CY2024Q3 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
0.0000005 usd
CY2023Q4 us-gaap Incentive To Lessee
IncentiveToLessee
286200 usd
CY2023Q4 us-gaap Line Of Credit Facility Periodic Payment
LineOfCreditFacilityPeriodicPayment
35775 usd
CY2024Q3 prso Amount Of Pending Lease Incentive
AmountOfPendingLeaseIncentive
107325 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
1000000 usd
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.08 pure
CY2022Q1 prso Lease Liability
LeaseLiability
274000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
124000 usd
CY2022Q4 prso Lease Liability
LeaseLiability
117000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
265000 usd
CY2024Q3 us-gaap Finance Lease Right Of Use Asset
FinanceLeaseRightOfUseAsset
90000 usd
CY2024Q3 prso Rightofuse Assets
RightofuseAssets
355000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
320000 usd
CY2024Q3 us-gaap Finance Lease Liability
FinanceLeaseLiability
91000 usd
CY2024Q3 prso Lease Liability
LeaseLiability
411000 usd
CY2024Q3 prso Lessee Operating And Financing Lease Liability Payments Reminder Fiscal Year
LesseeOperatingAndFinancingLeaseLiabilityPaymentsReminderFiscalYear
81000 usd
CY2024Q3 prso Lessee Operating And Financing Lease Liability Payments Due Next Twelve Months
LesseeOperatingAndFinancingLeaseLiabilityPaymentsDueNextTwelveMonths
164000 usd
CY2024Q3 prso Lessee Operatingand Financing Lease Liability Payments Due Year Two
LesseeOperatingandFinancingLeaseLiabilityPaymentsDueYearTwo
108000 usd
CY2024Q3 prso Lessee Operatingand Financing Lease Liability Payments Due Year Three
LesseeOperatingandFinancingLeaseLiabilityPaymentsDueYearThree
100000 usd
CY2024Q3 prso Lessee Operatingand Financing Lease Liability Payments Due
LesseeOperatingandFinancingLeaseLiabilityPaymentsDue
453000 usd
CY2024Q3 prso Lessee Operatingand Financing Lease Liability Undiscounted Excess Amount
LesseeOperatingandFinancingLeaseLiabilityUndiscountedExcessAmount
42000 usd
CY2024Q3 prso Lease Liabilities
LeaseLiabilities
411000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
319000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
492000 usd
CY2024Q3 us-gaap Payments For Rent
PaymentsForRent
200000 usd
CY2023Q3 us-gaap Payments For Rent
PaymentsForRent
200000 usd
us-gaap Payments For Rent
PaymentsForRent
400000 usd
us-gaap Payments For Rent
PaymentsForRent
600000 usd
CY2024Q3 us-gaap Recorded Unconditional Purchase Obligation Amount Of Maturities And Sinking Fund Requirements
RecordedUnconditionalPurchaseObligationAmountOfMaturitiesAndSinkingFundRequirements
2900000 usd
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1 pure
CY2024Q3 us-gaap Revenues
Revenues
3841000 usd
CY2023Q3 us-gaap Revenues
Revenues
4481000 usd
us-gaap Revenues
Revenues
10895000 usd
us-gaap Revenues
Revenues
11916000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1
ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
P10Y
prso Aggregate Exchangeable Shares
AggregateExchangeableShares
32822 shares
prso Exchangeable Shares Percentage
ExchangeableSharesPercentage
0.10 pure
prso Voting Power Percentage
VotingPowerPercentage
0.50 pure
CY2024Q1 prso Numberof Additional Share Issued
NumberofAdditionalShareIssued
285714 shares
CY2024Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
82500 shares
us-gaap Proceeds From Issuance Of Warrants
ProceedsFromIssuanceOfWarrants
3400000 usd
CY2024Q1 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
139108 shares
CY2024Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
2.625
CY2024Q3 prso Percentage Of Gross Proceeds
PercentageOfGrossProceeds
0.03 pure
CY2023Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
7000 shares
CY2023Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
28
CY2024Q1 us-gaap Class Of Warrant Or Righst Date From Which Warrants Or Rights Exercisable
ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable
2028-06-02
CY2024Q1 prso Prefundedwarrantsissued
Prefundedwarrantsissued
1425000 shares
CY2024Q1 prso Prefundedwarrantsissued Exercise Price
PrefundedwarrantsissuedExercisePrice
0.001
CY2024Q1 prso Prefundedwarrantsexercised
Prefundedwarrantsexercised
-1001000 shares
CY2024Q1 prso Exercise Price Prefunded Warrants Exercised
ExercisePricePrefundedWarrantsExercised
0.001
CY2024Q1 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8518000 shares
CY2024Q2 prso Prefundedwarrantsexercised
Prefundedwarrantsexercised
-307000 shares
CY2024Q2 prso Exercise Price Prefunded Warrants Exercised
ExercisePricePrefundedWarrantsExercised
0.001
CY2024Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8211000 shares
CY2024Q3 prso Exercise Price Warrant Activity
ExercisePriceWarrantActivity
0.001
CY2024Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8211000 shares
prso Percentage Of Fair Value Volatility
PercentageOfFairValueVolatility
1 pure
CY2024Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
30300 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
85600 usd
CY2023Q3 us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
28000 usd
us-gaap Employee Benefits And Share Based Compensation
EmployeeBenefitsAndShareBasedCompensation
83800 usd
us-gaap Asset Acquisition Consideration Transferred Transaction Cost
AssetAcquisitionConsiderationTransferredTransactionCost
3062500 usd
us-gaap Asset Acquisition Consideration Transferred Equity Interest Issued And Issuable
AssetAcquisitionConsiderationTransferredEquityInterestIssuedAndIssuable
437500 usd
CY2022 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
2600000 usd
CY2023Q3 us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
400000 usd
us-gaap Sale And Leaseback Transaction Gain Loss Net
SaleAndLeasebackTransactionGainLossNet
400000 usd
CY2024Q3 us-gaap Proceeds From Customers
ProceedsFromCustomers
200000 usd
us-gaap Proceeds From Customers
ProceedsFromCustomers
5700000 usd
CY2024Q3 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q3 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q3 prso Non Rule10b51 Arr Modified Flag
NonRule10b51ArrModifiedFlag
false
CY2024Q3 prso Rule10b51 Arr Modified Flag
Rule10b51ArrModifiedFlag
false
CY2024Q3 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false
CY2024Q3 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2023 us-gaap Common Stock Shares Authorized Unlimited
CommonStockSharesAuthorizedUnlimited
Unlimited
CY2024Q3 prso Severance And Software License Obligations
SeveranceAndSoftwareLicenseObligations
usd
us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
usd
CY2024Q2 prso Stock Issued During Period Share Exchangeof Exchangeable Shares
StockIssuedDuringPeriodShareExchangeofExchangeableShares
usd
CY2023Q1 prso Stock Issued During Period Share Exchangeof Exchangeable Shares
StockIssuedDuringPeriodShareExchangeofExchangeableShares
usd
CY2023Q3 prso Stock Issued During Period Share Exchangeof Exchangeable Shares
StockIssuedDuringPeriodShareExchangeofExchangeableShares
usd
CY2023Q3 prso Issuance Of Common Stock Under Stock Plan Net
IssuanceOfCommonStockUnderStockPlanNet
usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
usd
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
usd
us-gaap Proceeds From Sale And Maturity Of Marketable Securities
ProceedsFromSaleAndMaturityOfMarketableSecurities
usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
usd
prso Proceeds From Atthemarket Sales Of Stock Net
ProceedsFromAtthemarketSalesOfStockNet
usd
prso Initial Recognition Of Warrant Liability
InitialRecognitionOfWarrantLiability
usd
prso Unrealized Gainloss On Availableforsale Securities
UnrealizedGainlossOnAvailableforsaleSecurities
usd
CY2023Q4 us-gaap Program Rights Obligations
ProgramRightsObligations
usd
CY2023Q4 us-gaap Supplemental Unemployment Benefits Severance Benefits
SupplementalUnemploymentBenefitsSeveranceBenefits
usd
CY2024Q1 prso Expiration Prefunded Warrants Issued
ExpirationPrefundedWarrantsIssued
CY2024Q1 prso Expiration Prefunded Warrants Exercised
ExpirationPrefundedWarrantsExercised
CY2024Q2 prso Expiration Prefunded Warrants Exercised
ExpirationPrefundedWarrantsExercised
CY2024Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
CY2024Q3 prso Number Of Shares Warrant Activity
NumberOfSharesWarrantActivity
shares
CY2024Q3 prso Expiration Warrant Activity
ExpirationWarrantActivity
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Entity Central Index Key
EntityCentralIndexKey
0000890394

Files In Submission

Name View Source Status
0001213900-24-097140-index-headers.html Edgar Link pending
0001213900-24-097140-index.html Edgar Link pending
0001213900-24-097140.txt Edgar Link pending
0001213900-24-097140-xbrl.zip Edgar Link pending
ea0220447-10q_peraso.htm Edgar Link pending
ea022044701ex31-1_peraso.htm Edgar Link pending
ea022044701ex31-2_peraso.htm Edgar Link pending
ea022044701ex32-1_peraso.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
prso-20240930.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
prso-20240930_cal.xml Edgar Link unprocessable
prso-20240930_lab.xml Edgar Link unprocessable
prso-20240930_pre.xml Edgar Link unprocessable
ea0220447-10q_peraso_htm.xml Edgar Link completed
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
prso-20240930_def.xml Edgar Link unprocessable